NO841835L - Immunoproeve-hurtigmetode og apparatur dertil - Google Patents
Immunoproeve-hurtigmetode og apparatur dertilInfo
- Publication number
- NO841835L NO841835L NO841835A NO841835A NO841835L NO 841835 L NO841835 L NO 841835L NO 841835 A NO841835 A NO 841835A NO 841835 A NO841835 A NO 841835A NO 841835 L NO841835 L NO 841835L
- Authority
- NO
- Norway
- Prior art keywords
- filter
- tube
- plunger
- beads
- immunological
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 33
- 239000011324 bead Substances 0.000 claims description 75
- 238000012360 testing method Methods 0.000 claims description 39
- 239000012530 fluid Substances 0.000 claims description 35
- 230000001900 immune effect Effects 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 239000011148 porous material Substances 0.000 claims description 23
- 238000005406 washing Methods 0.000 claims description 19
- 210000000601 blood cell Anatomy 0.000 claims description 12
- 230000008021 deposition Effects 0.000 claims description 12
- 238000003018 immunoassay Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 239000000470 constituent Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 8
- 238000011161 development Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 230000000717 retained effect Effects 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 239000000427 antigen Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 102000036639 antigens Human genes 0.000 description 19
- 108091007433 antigens Proteins 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 238000000151 deposition Methods 0.000 description 12
- 238000010276 construction Methods 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 230000035484 reaction time Effects 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000013060 biological fluid Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000005712 elicitor Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- 108010088160 Staphylococcal Protein A Proteins 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013514 silicone foam Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
- G01N33/5304—Reaction vessels, e.g. agglutination plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Sampling And Sample Adjustment (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1983/001757 WO1985002260A1 (en) | 1983-11-08 | 1983-11-08 | Rapid plunger immunoassay method and apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO841835L true NO841835L (no) | 1985-05-23 |
Family
ID=22175563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO841835A NO841835L (no) | 1983-11-08 | 1984-05-08 | Immunoproeve-hurtigmetode og apparatur dertil |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0161247A4 (da) |
| JP (1) | JPS60501570A (da) |
| AU (1) | AU556193B2 (da) |
| DK (1) | DK525584A (da) |
| NO (1) | NO841835L (da) |
| WO (1) | WO1985002260A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5155021A (en) * | 1989-02-09 | 1992-10-13 | Eastman Kodak Company | Method and kit for determination of herpes simplex viral antigen by direct binding to polymeric particles |
| EP1131159A1 (en) * | 1998-11-18 | 2001-09-12 | Orchid BioSciences, Inc. | One-step nucleic acid dipstick device with movable membrane |
| EP1432811A4 (en) * | 2001-08-28 | 2005-02-16 | Wen-Tien Chen | CELL SEPARATION MATRIX |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3355098A (en) * | 1964-07-06 | 1967-11-28 | Bioconsultants Inc | Serum separation apparatus and method |
| US3481477A (en) * | 1965-03-02 | 1969-12-02 | Andrew F Farr | Apparatus for filtering out clear liquid from suspended solids |
| NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3512940A (en) * | 1968-12-30 | 1970-05-19 | Justin J Shapiro | Test tube filter device |
| US3661265A (en) * | 1970-07-27 | 1972-05-09 | Contemporary Research And Dev | Serum separator type container |
| US3954614A (en) * | 1972-07-31 | 1976-05-04 | Glasrock Products, Inc. | Serum skimmer and filter separation unit |
| US3955423A (en) * | 1972-09-18 | 1976-05-11 | Marvin Padover | Liquid sampling method |
| US3832141A (en) * | 1973-01-03 | 1974-08-27 | Glasrock Products | Pressure differential filtering apparatus |
| US4057499A (en) * | 1973-03-09 | 1977-11-08 | Buono Frank S | Apparatus and method for separation of blood |
| US3870639A (en) * | 1974-01-02 | 1975-03-11 | Moore Perk Corp | Filtering device |
| US3969250A (en) * | 1975-03-10 | 1976-07-13 | Farr Andrew F | Apparatus for preparing liquid samples for analysis in automatic analyzers |
| ZA761751B (en) * | 1975-04-07 | 1977-03-30 | Summa Corp | Immobilized immunoadsorbent |
-
1983
- 1983-11-08 AU AU23412/84A patent/AU556193B2/en not_active Ceased
- 1983-11-08 JP JP84500095A patent/JPS60501570A/ja active Pending
- 1983-11-08 EP EP19830903878 patent/EP0161247A4/en not_active Withdrawn
- 1983-11-08 WO PCT/US1983/001757 patent/WO1985002260A1/en not_active Application Discontinuation
-
1984
- 1984-05-08 NO NO841835A patent/NO841835L/no unknown
- 1984-11-05 DK DK525584A patent/DK525584A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK525584A (da) | 1985-05-23 |
| EP0161247A4 (en) | 1988-09-19 |
| WO1985002260A1 (en) | 1985-05-23 |
| AU2341284A (en) | 1985-06-03 |
| AU556193B2 (en) | 1986-10-23 |
| EP0161247A1 (en) | 1985-11-21 |
| JPS60501570A (ja) | 1985-09-19 |
| DK525584D0 (da) | 1984-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4424279A (en) | Rapid plunger immunoassay method and apparatus | |
| US4458020A (en) | Integrated single tube plunger immunoassay system having plural reagent chambers | |
| US4090850A (en) | Apparatus for use in radioimmunoassays | |
| US4632901A (en) | Method and apparatus for immunoassays | |
| EP0319294B1 (en) | Improved membrane assay using focused sample application | |
| US4053284A (en) | Continuous flow apparatus for biological testing | |
| US5077012A (en) | Device for detecting disease markers | |
| JP3299271B2 (ja) | 毛細管血液抗原試験装置 | |
| US5042502A (en) | Urine testing module with cytology cup | |
| EP0471570A1 (en) | Urine testing apparatus with urinary sediment and device | |
| CN105353159A (zh) | 微流体检验装置及其运作方法 | |
| CA2457930A1 (en) | Diagnostic testing process and apparatus | |
| EP0631667A4 (en) | ASSAY WITH IMPROVED SENSITIVITY OF THE CONCENTRATION CURVE. | |
| US5427739A (en) | Apparatus for performing immunoassays | |
| RU2115122C1 (ru) | Одноразовый реактор для твердофазного иммуноанализа и способ твердофазного иммуноанализа | |
| JP2000502451A (ja) | 血漿分離をもたらす診断分析 | |
| NO314206B1 (no) | Kvantitativt kjemisk analysemetode, anordning/innretning, samt anvendelse av nevnte metode og analysesett | |
| NO841835L (no) | Immunoproeve-hurtigmetode og apparatur dertil | |
| CA2570383A1 (en) | Filter device, the method, kit and use thereof | |
| CA1221627A (en) | Rapid plunger immunoassay method and apparatus | |
| NO860937L (no) | Diagnostikum for assaybestemmelser. | |
| KR910001313B1 (ko) | 면역 분석 방법 및 장치 | |
| JPS61213770A (ja) | ラテックス凝集反応測定用装置 | |
| JPH0238972A (ja) | 免疫学的測定機器及び方法 | |
| JPS58225354A (ja) | 免疫分析法 |